Retinal Dystrophies Clinical Trials

21 clinical trials for Retinal Dystrophies across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Real-time Acoustic Biofeedback for Enhancing Fixation Stability: A Proof-of-concept Study to Improve Ophthalmic Imaging Diagnostic Quality — RECRUITING · NA
• Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD) — RECRUITING
• Natural History Study of Inherited Retinal Diseases — RECRUITING
• SS-HH-OCT as a Novel Diagnostic Modality for Early-Onset Retinal Dystrophies (EORDs) — RECRUITING · NA
• The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration — RECRUITING · PHASE1
• EyeConic: Qualification for Cone-Optogenetics — RECRUITING
• Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration — RECRUITING
• Evaluation of Objective Perimetry Using Chromatic Multifocal Pupillometer — RECRUITING
• A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 Administered Intravitreally in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy, Including Participants Previously Treated With VP001 — ACTIVE_NOT_RECRUITING · PHASE1
• MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby) — COMPLETED · PHASE1
• Natural History of PRPF31 Mutation-Associated Retinal Dystrophy — ACTIVE_NOT_RECRUITING
• iPS Cells of Patients for Models of Retinal Dystrophies — COMPLETED · NA
• Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study — ACTIVE_NOT_RECRUITING
• Performance of Long-wavelength Autofluorescence Imaging — COMPLETED · NA
• Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE] — COMPLETED · PHASE2
• Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases — COMPLETED
• A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene — ACTIVE_NOT_RECRUITING · PHASE1
• Dual Wavelength OCT — COMPLETED
• An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) With LCA10 Caused by Mutations in the CEP290 Gene. — OTHER · PHASE2
• Optical Head-Mounted Display Technology for Low Vision Rehabilitation — COMPLETED · NA
• Intravitreal Ranibizumab (Lucentis®) in the Treatment of Non-leaking Macular Cysts in Retinal Dystrophy — COMPLETED · PHASE2

Refine this search